Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: Neurogastroenterol Motil. 2023 Nov 29;36(2):e14710. doi: 10.1111/nmo.14710

Table 4.

Correlations (r) between resilience and clinical measures

BRS CDRISC Relative resilience

IBS-SSS IBS-QOL IBS-SSS IBS-QOL IBS-SSS IBS-QOL

All IBS (n=232) −0.18* 0.33* −0.11 0.21* −0.15* 0.32*
Female IBS (n=170) −0.24* 0.36* −0.13 0.27* −0.15 0.33*
Male IBS (n=62) −0.03 0.29* −0.20 0.17 −0.27* 0.42*
*

p<0.05

IBS, irritable bowel syndrome; CDRISC, Connor-Davidson Resilience Scale; BRS, Brief Resilience Scale; IBS-SSS, IBS symptom severity; IBS-QOL, IBS-specific quality of life